» Authors » Canna Ghia

Canna Ghia

Explore the profile of Canna Ghia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 14
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Angulo F, Ghia C, Fletcher M, Ozbilgili E, Del Carmen Morales G
Anaerobe . 2024 Feb; 86:102821. PMID: 38336258
Background: Clostridioides difficile (formerly Clostridium difficile) is well-documented in Europe and North America to be a common cause of healthcare-associated gastrointestinal tract infections. In contrast, C difficile infection (CDI) is...
2.
Ghia C, Rambhad G
J Mark Access Health Policy . 2023 Mar; 11(1):2194507. PMID: 36998432
Introduction: The Indian healthcare system is evolving towards better healthcare implementation and coverage. However, even today, the health-care system faces several challenges, a few of which are yet to be...
3.
Ghia C, Rambhad G
Ther Adv Infect Dis . 2021 Sep; 8:20499361211045253. PMID: 34540226
, a Gram-positive bacterium, causes invasive infection known as Group B streptococcal disease (GBS). It is a leading cause of neonatal death and complications prior to delivery. The burden of...
4.
Ghia C, Rambhad G
Clin Med Insights Pediatr . 2021 Jul; 15:11795565211029250. PMID: 34285625
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infections in young children. Globally, there is huge disease burden, high treatment cost, and health impact...
5.
Ghia C, Wasserman M, Fletcher M, Farkouh R, Rambhad G
Value Health Reg Issues . 2018 Apr; 15:99-105. PMID: 29655052
Background: India is home to up to 28 million infants born annually, and yet to a large extent these children do not benefit from the protection provided by a pneumococcal...
6.
Ghia C, Akerkar S, Sabnis S, Rao U, Rambhad G
J Assoc Physicians India . 2016 Oct; 64(9):14-17. PMID: 27762509
Background / Objectives: Biologic anti-TNFs in India have improved the patient management. Significant proportions of patients lose response over time or do not respond. Possible explanations are suboptimal trough anti-TNFa...